Mitchell did mention that current data on some at-home ECG devices indicates a high likelihood of false positive results, ...

SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a $56.5 million market cap pioneer in medical technology currently trading at $2.12 per share, has announced the submission of a 510(k) ...

The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five clinical sites. The Company believes the study's findings support the clinical ...

Understand the significant growth trajectory of the Handheld ECG Devices segment, which is expected to reach US$1.9 Billion ...

HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...

The global cholesterol and lipid test market value is anticipated to expand from USD 3.0 billion in 2024 to USD 6.2 billion ...

The CDC says that almost half of Americans have at least one risk factor for heart disease. That's why you should get screenings regularly. Now let's dig into when you should. Hint: it's before ...

Advances in technology have made it increasingly easier for people to self-monitor their heart health whether it’s via a smart device on their wrist or finger or a blood pressure monitor. However, a ...

A GPS smartwatch that helps beginners gamify their fitness with car-like data and takes elite athletes to new levels.

The global cardiovascular devices market, valued at US$72.83 billion in 2023, is forecasted to grow at a robust CAGR of 7.3%, ...

So trust us when we say that the below deals are the best finds on Amazon this week. If you made a New Year’s Resolution to ...

A day that's all about heartwarming gestures, and a whole lot of love. But why wait for Feb 14 when you can be the one to ...